Well-tolerated radiotherapy provides longer life to patients with recurrent brai

[Bluebird]

Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer
18.05.2010

Patients who received hypofractionated stereotactic radiotherapy for their recurrent brain cancers lived longer lives, according to researchers at Thomas Jefferson University.

Not only does hypofractionated stereotactic radiotherapy (H-SRT) provide longer survival, patients do not experience side effects commonly seen with use of chemotherapies and targeted therapies, the researchers found. They believe these findings, reported online in the Journal of Clinical Oncology, set a new bar for the treatment of recurrent gliomas.
ff.

http://www.innovations-report.de/html/berichte/medizin_gesundheit/tolerated_radiotherapy_longer_life_patients_154863.html


Gut verträgliche Strahlentherapie verlängert das Leben von Patienten mit rezidivierenden Hirntumoren


Bluebird